Pharma Foods International: Announcements of individual stocks regarding the continued selection of stocks in the JPX Nikkei Small and Mid Cap Index.
Pharma Foods International: Announcements of individual stocks regarding the revision of the full-year performance forecast for the fiscal year ending July 2024 and the revision of dividend estimates (increased dividends).
Pharma Foods International: As stipulated in the exclusive license agreement between PFI and Takeda Pharmaceutical Company Limited, a milestone has been achieved.
Pharma Foods International: Announcements of individual stocks: Notice of milestone achievement based on the license agreement with Takeda Pharmaceutical Company Limited
Pharma Foods International: Confirmation letter
Pharma Foods International: Quarterly report - 27th period, 3rd quarter (02/01/2024 - 04/30/2024)
Pharma Foods International: Summary of consolidated financial results for the 9 months ended April 30, 2024 (based on Japanese accounting standards).
Pharma Foods International: Supplementary financial statement information for the third quarter of the fiscal year ending in July 2024.
Pharma Foods International: 3rd quarter financial report for the July 2024 period under Japanese accounting standards (consolidated).
Pharma Foods: Announcement of the full transcript of the financial results briefing for the 2nd quarter of the fiscal year ending 2024/7
Pharma Foods International: Corporate Governance Report 2024/03/22
Pharma Foods International: Financial results briefing materials for the 2nd quarter of the fiscal year ending July 2024
Pharma Foods International: (Delayed)Summary of Consolidated Financial Results for the Six Months Ended January 31, 2024 (Based on Japanese GAAP)
Pharma Foods: Confirmation Letter
Pharma Foods International: Quarterly Report - 27th Quarter 2 (2023/11/01 - 2024/01/31)
Pharma Foods: Summary of Financial Results for the 2nd Quarter Ending July 2024 [Japanese GAAP] (Consolidated)
Pharma Foods: Notice Concerning Revision of Full-Year Earnings Forecast for the Fiscal Year Ending July 2024
Pharma Foods International: Notice Concerning Determination of Dividends from Surplus Funds (Interim Dividends)
Pharma Foods: Corrected Report (Mass Ownership Report/Change Report)
Pharma Foods International: Treasury stock purchase status report (based on Act Section 24-6 (1))
No Data